Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torsten Haferlach

Showing results (51-60 of 596) with videos related to

Pageof 60
Sort By:
British Journal of Haematology|October 12, 2019
A decade with whole exome sequencing in haematologyMarcus C Hansen, Torsten Haferlach, Charlotte G Nyvold
Best Practice & Research. Clinical Haematology|August 25, 2009
Gene expression profiling in acute myeloid leukaemia (AML)Ulrike Bacher, Alexander Kohlmann, Claudia Haferlach, et al.
European Journal of Haematology|February 2, 2010
Severe idiopathic erythroblastic synartesis: successful treatment with the anti-CD20 monoclonal antibody rituximabGeorgios Papakonstantinou, Helmut Loeffler, Torsten Haferlach, et al.
Cancer|November 15, 2007
Monitoring of minimal residual disease in acute myeloid leukemiaWolfgang Kern, Claudia Haferlach, Torsten Haferlach, et al.
Leukemia & Lymphoma|October 11, 2007
Advanced age and high initial WBC influence the outcome of inv(3) (q21q26)/t(3;3) (q21;q26) positive AMLMartin Weisser, Claudia Haferlach, Torsten Haferlach, et al.
Critical Reviews in Oncology/Hematology|October 11, 2005
Monitoring of minimal residual disease in acute myeloid leukemiaWolfgang Kern, Claudia Schoch, Torsten Haferlach, et al.
Leukemia & Lymphoma|October 23, 2013
Perspective on how to approach molecular diagnostics in acute myeloid leukemia and myelodysplastic syndromes in the era of next-generation sequencingAlexander Kohlmann, Ulrike Bacher, Susanne Schnittger, et al.
Genes, Chromosomes & Cancer|September 4, 2014
Analysis for loss of heterozygosity on chromosome arm 13q by STR analysis or SNP sequencing can replace analysis of FLT3-ITD to detect patients with prognostically adverse AMLSusanne Schnittger, Claudia Haferlach, Wolfgang Kern, et al.
Leukemia & Lymphoma|January 12, 2011
Acute monoblastic/monocytic leukemia and chronic myelomonocytic leukemia share common immunophenotypic features but differ in the extent of aberrantly expressed antigens and amount of granulocytic cellsWolfgang Kern, Ulrike Bacher, Claudia Haferlach, et al.
Best Practice & Research. Clinical Haematology|November 30, 2010
The role of multiparameter flow cytometry for disease monitoring in AMLWolfgang Kern, Ulrike Bacher, Claudia Haferlach, et al.
Pageof 60

Showing results (51-60 of 596) with videos related to

Sort By:
Pageof 60
British Journal of Haematology|October 12, 2019
A decade with whole exome sequencing in haematologyMarcus C Hansen, Torsten Haferlach, Charlotte G Nyvold
Best Practice & Research. Clinical Haematology|August 25, 2009
Gene expression profiling in acute myeloid leukaemia (AML)Ulrike Bacher, Alexander Kohlmann, Claudia Haferlach, et al.
European Journal of Haematology|February 2, 2010
Severe idiopathic erythroblastic synartesis: successful treatment with the anti-CD20 monoclonal antibody rituximabGeorgios Papakonstantinou, Helmut Loeffler, Torsten Haferlach, et al.
Cancer|November 15, 2007
Monitoring of minimal residual disease in acute myeloid leukemiaWolfgang Kern, Claudia Haferlach, Torsten Haferlach, et al.
Leukemia & Lymphoma|October 11, 2007
Advanced age and high initial WBC influence the outcome of inv(3) (q21q26)/t(3;3) (q21;q26) positive AMLMartin Weisser, Claudia Haferlach, Torsten Haferlach, et al.
Critical Reviews in Oncology/Hematology|October 11, 2005
Monitoring of minimal residual disease in acute myeloid leukemiaWolfgang Kern, Claudia Schoch, Torsten Haferlach, et al.
Leukemia & Lymphoma|October 23, 2013
Perspective on how to approach molecular diagnostics in acute myeloid leukemia and myelodysplastic syndromes in the era of next-generation sequencingAlexander Kohlmann, Ulrike Bacher, Susanne Schnittger, et al.
Genes, Chromosomes & Cancer|September 4, 2014
Analysis for loss of heterozygosity on chromosome arm 13q by STR analysis or SNP sequencing can replace analysis of FLT3-ITD to detect patients with prognostically adverse AMLSusanne Schnittger, Claudia Haferlach, Wolfgang Kern, et al.
Leukemia & Lymphoma|January 12, 2011
Acute monoblastic/monocytic leukemia and chronic myelomonocytic leukemia share common immunophenotypic features but differ in the extent of aberrantly expressed antigens and amount of granulocytic cellsWolfgang Kern, Ulrike Bacher, Claudia Haferlach, et al.
Best Practice & Research. Clinical Haematology|November 30, 2010
The role of multiparameter flow cytometry for disease monitoring in AMLWolfgang Kern, Ulrike Bacher, Claudia Haferlach, et al.
Pageof 60